RICE HALL JAMES & ASSOCIATES, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$5,180,680
+19.6%
57,833
+13.7%
0.33%
+33.7%
Q2 2023$4,330,306
-10.9%
50,861
-13.4%
0.25%
-10.9%
Q1 2023$4,858,584
+17.4%
58,714
+11.6%
0.28%
+16.5%
Q4 2022$4,139,035
-32.3%
52,626
-36.3%
0.24%
-33.2%
Q3 2022$6,117,000
+21.4%
82,623
+6.9%
0.36%
+45.5%
Q2 2022$5,040,000
+4.0%
77,326
+0.9%
0.24%
+26.4%
Q1 2022$4,845,000
+57.8%
76,645
+32.4%
0.19%
+77.1%
Q4 2021$3,070,000
+0.6%
57,879
+33.9%
0.11%
-3.5%
Q3 2021$3,052,000
-36.2%
43,232
-63.4%
0.11%
-51.5%
Q1 2017$4,786,000
-8.6%
117,978
-9.4%
0.23%
-11.7%
Q4 2016$5,237,000
+10.8%
130,268
-0.2%
0.26%
+6.9%
Q3 2016$4,728,000
+40.5%
130,571
+12.4%
0.25%
+27.3%
Q2 2016$3,366,000
-15.9%
116,121
+1.4%
0.19%
-16.0%
Q1 2016$4,004,000
+11.6%
114,476
+2.9%
0.23%
+12.7%
Q4 2015$3,588,000
+76.3%
111,280
+76.7%
0.20%
+55.3%
Q3 2015$2,035,000
-84.1%
62,977
-79.2%
0.13%
-85.7%
Q4 2013$12,765,000
+36.1%
302,993
+28.9%
0.92%
+2.3%
Q3 2013$9,377,000
-12.0%
235,120
-8.8%
0.90%
-14.4%
Q2 2013$10,659,000257,7831.05%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders